Reply  to the Letter to the Editor “Visual outcomes after pituitary surgery”

Sven Berkmann; Javier Fandino; Beat Müller; Karl F. Kothbauer; Christoph Henzen; Hans Landolt

doi:10.4414/smw.2013.13803

Author reply to technical comment

Vol. 143 No. 2122 (2013)

Reply to the Letter to the Editor “Visual outcomes after pituitary surgery”

Sven Berkmann
Javier Fandino
Beat Müller
Karl F. Kothbauer
Christoph Henzen
Hans Landolt

Cite this as:: Swiss Med Wkly. 2013;143:w13803
Published: 19.05.2013

References

Berkmann S, Fandino J, Muller B, Kothbauer K, Henzen C, Landolt H. Pituitary surgery: experience from a large network in Central Switzerland. Swiss Med Wkly. 2012;142:w13680.
Berkmann S, Fandino J, Muller B, Remonda L, Landolt H. Intraoperative MRI and endocrinological outcome of transsphenoidal surgery for non-functioning pituitary adenoma. Acta Neurochir. (Wien) 2012;154:639–47.
Berkmann S, Fandino J, Zosso S, Killer HE, Remonda L, Landolt H. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. J Neurosurg. 2011;115:518–27.
Powell M. Recovery of vision following transsphenoidal surgery for pituitary adenomas. Br J Neurosurg. 1995;9:367–73.
Cohen AR, Cooper PR, Kupersmith MJ, Flamm ES, Ransohoff J. Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery. 1985;17:446–52.
Findlay G, McFadzean RM, Teasdale G. Recovery of vision following treatment of pituitary tumours; application of a new system of assessment to patients treated by transsphenoidal operation. Acta Neurochir. (Wien) 1983;68:175–86.
Harris PE, Afshar F, Coates P, et al. The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. Q J Med. 1989;71:417–27.
Laws ER, Jr., Trautmann JC, Hollenhorst RW, Jr. Transsphenoidal decompression of the optic nerve and chiasm. Visual results in 62 patients. J Neurosurg. 1977;46:717–22.
Fahlbusch R, Keller B, Ganslandt O, Kreutzer J, Nimsky C. Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging. Eur J Endocrinol. 2005;153:239–48.
Schwartz TH, Stieg PE, Anand VK. Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging. Neurosurgery. 2006;58:ONS44–51; discussion ONS44–51.
Gerlach R, du Mesnil de Rochemont R, Gasser T, et al. Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases. Neurosurgery. 2008;63:272–84; discussion 84–5.
Baumann F, Schmid C, Bernays RL. Intraoperative magnetic resonance imaging-guided transsphenoidal surgery for giant pituitary adenomas. Neurosurg Rev. 2010;33:83–90.

How to Cite

1.

Reply to the Letter to the Editor “Visual outcomes after pituitary surgery”. Swiss Med Wkly [Internet]. 2013 May 19 [cited 2025 Oct. 13];143(2122):w13803. Available from: https://www.smw.ch/index.php/smw/article/view/1693

Share

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

DOI:: https://doi.org/10.4414/smw.2013.13803

[1] Berkmann S, Fandino J, Muller B, Kothbauer K, Henzen C, Landolt H. Pituitary surgery: experience from a large network in Central Switzerland. Swiss Med Wkly. 2012;142:w13680.

[2] Berkmann S, Fandino J, Muller B, Remonda L, Landolt H. Intraoperative MRI and endocrinological outcome of transsphenoidal surgery for non-functioning pituitary adenoma. Acta Neurochir. (Wien) 2012;154:639–47.

[3] Berkmann S, Fandino J, Zosso S, Killer HE, Remonda L, Landolt H. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. J Neurosurg. 2011;115:518–27.

[4] Powell M. Recovery of vision following transsphenoidal surgery for pituitary adenomas. Br J Neurosurg. 1995;9:367–73.

[5] Cohen AR, Cooper PR, Kupersmith MJ, Flamm ES, Ransohoff J. Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery. 1985;17:446–52.

[6] Findlay G, McFadzean RM, Teasdale G. Recovery of vision following treatment of pituitary tumours; application of a new system of assessment to patients treated by transsphenoidal operation. Acta Neurochir. (Wien) 1983;68:175–86.

[7] Harris PE, Afshar F, Coates P, et al. The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. Q J Med. 1989;71:417–27.

[8] Laws ER, Jr., Trautmann JC, Hollenhorst RW, Jr. Transsphenoidal decompression of the optic nerve and chiasm. Visual results in 62 patients. J Neurosurg. 1977;46:717–22.

[9] Fahlbusch R, Keller B, Ganslandt O, Kreutzer J, Nimsky C. Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging. Eur J Endocrinol. 2005;153:239–48.

[10] Schwartz TH, Stieg PE, Anand VK. Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging. Neurosurgery. 2006;58:ONS44–51; discussion ONS44–51.

[11] Gerlach R, du Mesnil de Rochemont R, Gasser T, et al. Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases. Neurosurgery. 2008;63:272–84; discussion 84–5.

[12] Baumann F, Schmid C, Bernays RL. Intraoperative magnetic resonance imaging-guided transsphenoidal surgery for giant pituitary adenomas. Neurosurg Rev. 2010;33:83–90.